Objective changes in trypsin, alpha 1-antitrypsin, and alpha 2-macroglobulin values as a result of sodium fluoride treatment in patients with otosclerosis.
Causse
J R
JR
Uriel
J
J
Berges
J
J
Bretlau
P
P
Shambaugh
G E
GE
Causse
J B
JB
D006801:Humans; D010040:Otosclerosis / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D010498:Perilymph / Q000378:metabolism; D012969:Sodium Fluoride / Q000627:therapeutic use*; D014357:Trypsin / Q000378:metabolism*; D014361:Trypsin Inhibitors / Q000627:therapeutic use; D000515:alpha 1-Antitrypsin / Q000378:metabolism*; D000511:alpha-Macroglobulins / Q000378:metabolism*
D014361:Trypsin Inhibitors; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins; D012969:Sodium Fluoride; D014357:Trypsin